nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketazolam—ABCB1—Parkinson's disease	0.783	1	CbGaD
Ketazolam—GABRA1—hindbrain—Parkinson's disease	0.00566	0.0397	CbGeAlD
Ketazolam—GABRD—forebrain—Parkinson's disease	0.00503	0.0353	CbGeAlD
Ketazolam—GABRG1—forebrain—Parkinson's disease	0.00484	0.034	CbGeAlD
Ketazolam—GABRD—medulla oblongata—Parkinson's disease	0.00363	0.0255	CbGeAlD
Ketazolam—GABRG1—medulla oblongata—Parkinson's disease	0.0035	0.0246	CbGeAlD
Ketazolam—GABRB1—medulla oblongata—Parkinson's disease	0.00339	0.0238	CbGeAlD
Ketazolam—TSPO—embryo—Parkinson's disease	0.00339	0.0238	CbGeAlD
Ketazolam—GABRD—midbrain—Parkinson's disease	0.00332	0.0233	CbGeAlD
Ketazolam—GABRA1—brainstem—Parkinson's disease	0.00324	0.0228	CbGeAlD
Ketazolam—GABRG1—midbrain—Parkinson's disease	0.0032	0.0224	CbGeAlD
Ketazolam—GABRA1—forebrain—Parkinson's disease	0.00313	0.022	CbGeAlD
Ketazolam—GABRG1—spinal cord—Parkinson's disease	0.00312	0.0219	CbGeAlD
Ketazolam—TSPO—brainstem—Parkinson's disease	0.00311	0.0218	CbGeAlD
Ketazolam—GABRB1—midbrain—Parkinson's disease	0.0031	0.0218	CbGeAlD
Ketazolam—GABRB1—spinal cord—Parkinson's disease	0.00303	0.0212	CbGeAlD
Ketazolam—TSPO—forebrain—Parkinson's disease	0.003	0.021	CbGeAlD
Ketazolam—GABRD—head—Parkinson's disease	0.00288	0.0202	CbGeAlD
Ketazolam—GABRG1—head—Parkinson's disease	0.00277	0.0195	CbGeAlD
Ketazolam—GABRD—nervous system—Parkinson's disease	0.00273	0.0192	CbGeAlD
Ketazolam—GABRB1—head—Parkinson's disease	0.00269	0.0189	CbGeAlD
Ketazolam—GABRD—central nervous system—Parkinson's disease	0.00263	0.0185	CbGeAlD
Ketazolam—GABRG1—nervous system—Parkinson's disease	0.00263	0.0185	CbGeAlD
Ketazolam—GABRD—cerebellum—Parkinson's disease	0.00257	0.018	CbGeAlD
Ketazolam—GABRB1—nervous system—Parkinson's disease	0.00255	0.0179	CbGeAlD
Ketazolam—TSPO—cardiovascular system—Parkinson's disease	0.00254	0.0178	CbGeAlD
Ketazolam—GABRG1—central nervous system—Parkinson's disease	0.00253	0.0178	CbGeAlD
Ketazolam—GABRG1—cerebellum—Parkinson's disease	0.00247	0.0174	CbGeAlD
Ketazolam—GABRB1—central nervous system—Parkinson's disease	0.00245	0.0172	CbGeAlD
Ketazolam—GABRB1—cerebellum—Parkinson's disease	0.0024	0.0168	CbGeAlD
Ketazolam—GABRA1—medulla oblongata—Parkinson's disease	0.00226	0.0159	CbGeAlD
Ketazolam—TSPO—medulla oblongata—Parkinson's disease	0.00217	0.0152	CbGeAlD
Ketazolam—GABRD—brain—Parkinson's disease	0.00209	0.0147	CbGeAlD
Ketazolam—GABRA1—midbrain—Parkinson's disease	0.00207	0.0145	CbGeAlD
Ketazolam—GABRA1—spinal cord—Parkinson's disease	0.00202	0.0142	CbGeAlD
Ketazolam—GABRG1—brain—Parkinson's disease	0.00201	0.0141	CbGeAlD
Ketazolam—TSPO—midbrain—Parkinson's disease	0.00198	0.0139	CbGeAlD
Ketazolam—GABRB1—brain—Parkinson's disease	0.00195	0.0137	CbGeAlD
Ketazolam—TSPO—spinal cord—Parkinson's disease	0.00193	0.0136	CbGeAlD
Ketazolam—GABRE—head—Parkinson's disease	0.00184	0.0129	CbGeAlD
Ketazolam—GABRA1—head—Parkinson's disease	0.00179	0.0126	CbGeAlD
Ketazolam—GABRE—nervous system—Parkinson's disease	0.00174	0.0122	CbGeAlD
Ketazolam—TSPO—head—Parkinson's disease	0.00172	0.012	CbGeAlD
Ketazolam—GABRA1—nervous system—Parkinson's disease	0.0017	0.0119	CbGeAlD
Ketazolam—GABRE—central nervous system—Parkinson's disease	0.00168	0.0118	CbGeAlD
Ketazolam—GABRA1—central nervous system—Parkinson's disease	0.00164	0.0115	CbGeAlD
Ketazolam—TSPO—nervous system—Parkinson's disease	0.00163	0.0114	CbGeAlD
Ketazolam—GABRA1—cerebellum—Parkinson's disease	0.0016	0.0112	CbGeAlD
Ketazolam—TSPO—central nervous system—Parkinson's disease	0.00157	0.011	CbGeAlD
Ketazolam—TSPO—cerebellum—Parkinson's disease	0.00153	0.0107	CbGeAlD
Ketazolam—GABRE—brain—Parkinson's disease	0.00133	0.00935	CbGeAlD
Ketazolam—GABRA1—brain—Parkinson's disease	0.0013	0.00911	CbGeAlD
Ketazolam—TSPO—brain—Parkinson's disease	0.00124	0.00873	CbGeAlD
Ketazolam—ALB—brain—Parkinson's disease	0.00121	0.00853	CbGeAlD
Ketazolam—ABCB1—embryo—Parkinson's disease	0.00112	0.00783	CbGeAlD
Ketazolam—ABCB1—forebrain—Parkinson's disease	0.000986	0.00692	CbGeAlD
Ketazolam—ABCB1—cardiovascular system—Parkinson's disease	0.000834	0.00585	CbGeAlD
Ketazolam—CYP3A4—nervous system—Parkinson's disease	0.000756	0.00531	CbGeAlD
Ketazolam—CYP3A4—central nervous system—Parkinson's disease	0.000728	0.00511	CbGeAlD
Ketazolam—ABCB1—medulla oblongata—Parkinson's disease	0.000713	0.005	CbGeAlD
Ketazolam—ABCB1—midbrain—Parkinson's disease	0.000651	0.00457	CbGeAlD
Ketazolam—ABCB1—spinal cord—Parkinson's disease	0.000635	0.00446	CbGeAlD
Ketazolam—ABCB1—head—Parkinson's disease	0.000565	0.00396	CbGeAlD
Ketazolam—ABCB1—nervous system—Parkinson's disease	0.000535	0.00376	CbGeAlD
Ketazolam—ABCB1—central nervous system—Parkinson's disease	0.000516	0.00362	CbGeAlD
Ketazolam—ABCB1—cerebellum—Parkinson's disease	0.000504	0.00354	CbGeAlD
Ketazolam—Flunitrazepam—CYP2E1—Parkinson's disease	0.000457	0.272	CrCbGaD
Ketazolam—ABCB1—brain—Parkinson's disease	0.000409	0.00287	CbGeAlD
Ketazolam—Midazolam—CYP2E1—Parkinson's disease	0.00034	0.202	CrCbGaD
Ketazolam—Diazepam—CYP2E1—Parkinson's disease	0.000292	0.173	CrCbGaD
Ketazolam—GABRA1—SIDS Susceptibility Pathways—HTR1A—Parkinson's disease	0.00029	0.00398	CbGpPWpGaD
Ketazolam—GABRA1—SIDS Susceptibility Pathways—TAC1—Parkinson's disease	0.000286	0.00392	CbGpPWpGaD
Ketazolam—ALB—Platelet degranulation—FGB—Parkinson's disease	0.000285	0.00391	CbGpPWpGaD
Ketazolam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—Parkinson's disease	0.000283	0.00388	CbGpPWpGaD
Ketazolam—ALB—Selenium Micronutrient Network—INSR—Parkinson's disease	0.000279	0.00383	CbGpPWpGaD
Ketazolam—GABRB1—Neuronal System—CHRNA4—Parkinson's disease	0.000277	0.0038	CbGpPWpGaD
Ketazolam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIN2B—Parkinson's disease	0.000277	0.00379	CbGpPWpGaD
Ketazolam—ALB—Vitamin B12 Metabolism—SOD2—Parkinson's disease	0.000273	0.00375	CbGpPWpGaD
Ketazolam—ALB—Response to elevated platelet cytosolic Ca2+—FGB—Parkinson's disease	0.000272	0.00373	CbGpPWpGaD
Ketazolam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—Parkinson's disease	0.000268	0.00368	CbGpPWpGaD
Ketazolam—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—Parkinson's disease	0.000267	0.00366	CbGpPWpGaD
Ketazolam—Clobazam—ABCB1—Parkinson's disease	0.000262	0.156	CrCbGaD
Ketazolam—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—ABL1—Parkinson's disease	0.000262	0.00359	CbGpPWpGaD
Ketazolam—GABRB1—Transmission across Chemical Synapses—COMT—Parkinson's disease	0.000255	0.0035	CbGpPWpGaD
Ketazolam—GABRB1—Neuronal System—HSPA8—Parkinson's disease	0.000254	0.00349	CbGpPWpGaD
Ketazolam—GABRB1—Transmission across Chemical Synapses—MAOA—Parkinson's disease	0.000253	0.00347	CbGpPWpGaD
Ketazolam—GABRA1—SIDS Susceptibility Pathways—TH—Parkinson's disease	0.00025	0.00343	CbGpPWpGaD
Ketazolam—GABRA1—Transmission across Chemical Synapses—CHRNA4—Parkinson's disease	0.000247	0.00339	CbGpPWpGaD
Ketazolam—GABRA1—Neuronal System—GRIK2—Parkinson's disease	0.000247	0.00339	CbGpPWpGaD
Ketazolam—ALB—Folate Metabolism—SOD1—Parkinson's disease	0.000247	0.00339	CbGpPWpGaD
Ketazolam—GABRA1—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	0.000243	0.00333	CbGpPWpGaD
Ketazolam—GABRA1—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	0.000243	0.00333	CbGpPWpGaD
Ketazolam—ALB—Vitamin B12 Metabolism—MTHFR—Parkinson's disease	0.00024	0.0033	CbGpPWpGaD
Ketazolam—GABRA1—Neuronal System—SLC18A2—Parkinson's disease	0.000239	0.00328	CbGpPWpGaD
Ketazolam—GABRB1—Neuronal System—DLG4—Parkinson's disease	0.000239	0.00327	CbGpPWpGaD
Ketazolam—GABRB1—Neuronal System—GRIN2B—Parkinson's disease	0.000233	0.0032	CbGpPWpGaD
Ketazolam—GABRB1—Neuronal System—SLC6A3—Parkinson's disease	0.00023	0.00315	CbGpPWpGaD
Ketazolam—ALB—Lipid and lipoprotein metabolism—APOE—Parkinson's disease	0.000227	0.00312	CbGpPWpGaD
Ketazolam—GABRA1—Transmission across Chemical Synapses—HSPA8—Parkinson's disease	0.000227	0.00311	CbGpPWpGaD
Ketazolam—ALB—Vitamin B12 Metabolism—APOE—Parkinson's disease	0.000224	0.00307	CbGpPWpGaD
Ketazolam—ALB—Folate Metabolism—SOD2—Parkinson's disease	0.000222	0.00305	CbGpPWpGaD
Ketazolam—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—Parkinson's disease	0.00022	0.00301	CbGpPWpGaD
Ketazolam—ALB—FOXA2 and FOXA3 transcription factor networks—INS—Parkinson's disease	0.000215	0.00295	CbGpPWpGaD
Ketazolam—GABRA1—Transmission across Chemical Synapses—DLG4—Parkinson's disease	0.000213	0.00292	CbGpPWpGaD
Ketazolam—ALB—Folate Metabolism—GPX1—Parkinson's disease	0.000212	0.00291	CbGpPWpGaD
Ketazolam—ALB—Platelet degranulation—SOD1—Parkinson's disease	0.000212	0.0029	CbGpPWpGaD
Ketazolam—GABRA1—SIDS Susceptibility Pathways—MAOA—Parkinson's disease	0.000211	0.00289	CbGpPWpGaD
Ketazolam—CYP3A4—Tryptophan metabolism—CYP2E1—Parkinson's disease	0.000211	0.00289	CbGpPWpGaD
Ketazolam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—Parkinson's disease	0.000209	0.00287	CbGpPWpGaD
Ketazolam—ABCB1—HIF-1-alpha transcription factor network—HMOX1—Parkinson's disease	0.000208	0.00286	CbGpPWpGaD
Ketazolam—GABRA1—Transmission across Chemical Synapses—GRIN2B—Parkinson's disease	0.000208	0.00285	CbGpPWpGaD
Ketazolam—GABRA1—Transmission across Chemical Synapses—SLC6A3—Parkinson's disease	0.000205	0.00281	CbGpPWpGaD
Ketazolam—GABRA1—SIDS Susceptibility Pathways—BDNF—Parkinson's disease	0.000204	0.00279	CbGpPWpGaD
Ketazolam—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.000203	0.00278	CbGpPWpGaD
Ketazolam—ALB—Response to elevated platelet cytosolic Ca2+—SOD1—Parkinson's disease	0.000202	0.00277	CbGpPWpGaD
Ketazolam—ALB—Platelet degranulation—IGF2—Parkinson's disease	0.000201	0.00276	CbGpPWpGaD
Ketazolam—ABCB1—HIF-1-alpha transcription factor network—EDN1—Parkinson's disease	0.000196	0.00269	CbGpPWpGaD
Ketazolam—ALB—Selenium Micronutrient Network—SOD1—Parkinson's disease	0.000196	0.00269	CbGpPWpGaD
Ketazolam—ALB—Folate Metabolism—MTHFR—Parkinson's disease	0.000196	0.00268	CbGpPWpGaD
Ketazolam—GABRB1—Neuronal System—COMT—Parkinson's disease	0.000195	0.00268	CbGpPWpGaD
Ketazolam—GABRB1—Neuronal System—MAOA—Parkinson's disease	0.000194	0.00266	CbGpPWpGaD
Ketazolam—ALB—Response to elevated platelet cytosolic Ca2+—IGF2—Parkinson's disease	0.000191	0.00263	CbGpPWpGaD
Ketazolam—ALB—Vitamin B12 Metabolism—INS—Parkinson's disease	0.000191	0.00262	CbGpPWpGaD
Ketazolam—ALB—Platelet degranulation—HGF—Parkinson's disease	0.00019	0.0026	CbGpPWpGaD
Ketazolam—GABRA1—Neuronal System—CHRNA4—Parkinson's disease	0.000189	0.0026	CbGpPWpGaD
Ketazolam—GABRB1—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000188	0.00258	CbGpPWpGaD
Ketazolam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	0.000186	0.00255	CbGpPWpGaD
Ketazolam—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	0.000184	0.00252	CbGpPWpGaD
Ketazolam—ALB—Response to elevated platelet cytosolic Ca2+—HGF—Parkinson's disease	0.000181	0.00248	CbGpPWpGaD
Ketazolam—GABRA1—SIDS Susceptibility Pathways—NGF—Parkinson's disease	0.000181	0.00248	CbGpPWpGaD
Ketazolam—ALB—Hemostasis—MERTK—Parkinson's disease	0.00018	0.00247	CbGpPWpGaD
Ketazolam—ALB—Hemostasis—DOCK3—Parkinson's disease	0.00018	0.00247	CbGpPWpGaD
Ketazolam—Midazolam—ABCB1—Parkinson's disease	0.000178	0.106	CrCbGaD
Ketazolam—ALB—Selenium Micronutrient Network—SOD2—Parkinson's disease	0.000177	0.00242	CbGpPWpGaD
Ketazolam—ABCB1—Integrated Pancreatic Cancer Pathway—MAP3K5—Parkinson's disease	0.000176	0.00241	CbGpPWpGaD
Ketazolam—GABRA1—Transmission across Chemical Synapses—COMT—Parkinson's disease	0.000174	0.00239	CbGpPWpGaD
Ketazolam—GABRA1—Neuronal System—HSPA8—Parkinson's disease	0.000174	0.00238	CbGpPWpGaD
Ketazolam—GABRB1—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000173	0.00238	CbGpPWpGaD
Ketazolam—GABRA1—Transmission across Chemical Synapses—MAOA—Parkinson's disease	0.000173	0.00237	CbGpPWpGaD
Ketazolam—GABRA1—SIDS Susceptibility Pathways—HTR2A—Parkinson's disease	0.000172	0.00236	CbGpPWpGaD
Ketazolam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.00017	0.00234	CbGpPWpGaD
Ketazolam—ALB—Selenium Micronutrient Network—GPX1—Parkinson's disease	0.000168	0.00231	CbGpPWpGaD
Ketazolam—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.000168	0.0023	CbGpPWpGaD
Ketazolam—GABRA1—Neuronal System—DLG4—Parkinson's disease	0.000163	0.00224	CbGpPWpGaD
Ketazolam—ALB—Hemostasis—DGKQ—Parkinson's disease	0.00016	0.0022	CbGpPWpGaD
Ketazolam—GABRA1—Neuronal System—GRIN2B—Parkinson's disease	0.000159	0.00219	CbGpPWpGaD
Ketazolam—GABRA1—Neuronal System—SLC6A3—Parkinson's disease	0.000157	0.00215	CbGpPWpGaD
Ketazolam—ABCB1—Allograft Rejection—FASLG—Parkinson's disease	0.000156	0.00214	CbGpPWpGaD
Ketazolam—ALB—Folate Metabolism—INS—Parkinson's disease	0.000156	0.00214	CbGpPWpGaD
Ketazolam—ALB—Selenium Micronutrient Network—MTHFR—Parkinson's disease	0.000155	0.00213	CbGpPWpGaD
Ketazolam—Diazepam—ABCB1—Parkinson's disease	0.000153	0.0908	CrCbGaD
Ketazolam—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.000151	0.00207	CbGpPWpGaD
Ketazolam—ABCB1—Integrated Pancreatic Cancer Pathway—MAPT—Parkinson's disease	0.000146	0.002	CbGpPWpGaD
Ketazolam—ALB—SLC-mediated transmembrane transport—SLC18A2—Parkinson's disease	0.000145	0.00199	CbGpPWpGaD
Ketazolam—ALB—Vitamin B12 Metabolism—IL1B—Parkinson's disease	0.000143	0.00196	CbGpPWpGaD
Ketazolam—ALB—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	0.000139	0.0019	CbGpPWpGaD
Ketazolam—ALB—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	0.000139	0.0019	CbGpPWpGaD
Ketazolam—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.000138	0.00189	CbGpPWpGaD
Ketazolam—GABRA1—Neuronal System—COMT—Parkinson's disease	0.000133	0.00183	CbGpPWpGaD
Ketazolam—ALB—SLC-mediated transmembrane transport—CP—Parkinson's disease	0.000133	0.00183	CbGpPWpGaD
Ketazolam—GABRA1—Neuronal System—MAOA—Parkinson's disease	0.000133	0.00182	CbGpPWpGaD
Ketazolam—GABRA1—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000129	0.00177	CbGpPWpGaD
Ketazolam—ALB—Platelet activation, signaling and aggregation—FGB—Parkinson's disease	0.000126	0.00173	CbGpPWpGaD
Ketazolam—ALB—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	0.000124	0.0017	CbGpPWpGaD
Ketazolam—ALB—Selenium Micronutrient Network—INS—Parkinson's disease	0.000124	0.0017	CbGpPWpGaD
Ketazolam—GABRB1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000124	0.00169	CbGpPWpGaD
Ketazolam—ABCB1—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	0.000122	0.00167	CbGpPWpGaD
Ketazolam—ABCB1—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	0.000122	0.00167	CbGpPWpGaD
Ketazolam—CYP3A4—Biological oxidations—GSTA4—Parkinson's disease	0.000121	0.00166	CbGpPWpGaD
Ketazolam—CYP3A4—Metapathway biotransformation—GSTA4—Parkinson's disease	0.000119	0.00164	CbGpPWpGaD
Ketazolam—GABRB1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000119	0.00163	CbGpPWpGaD
Ketazolam—GABRA1—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000118	0.00162	CbGpPWpGaD
Ketazolam—ALB—Folate Metabolism—IL1B—Parkinson's disease	0.000116	0.00159	CbGpPWpGaD
Ketazolam—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000114	0.00156	CbGpPWpGaD
Ketazolam—CYP3A4—Biological oxidations—MAOB—Parkinson's disease	0.000108	0.00148	CbGpPWpGaD
Ketazolam—ALB—Vitamin B12 Metabolism—TNF—Parkinson's disease	0.000104	0.00142	CbGpPWpGaD
Ketazolam—ALB—Hemostasis—MAG—Parkinson's disease	0.000103	0.00142	CbGpPWpGaD
Ketazolam—GABRB1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000103	0.00141	CbGpPWpGaD
Ketazolam—GABRA1—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	0.000102	0.0014	CbGpPWpGaD
Ketazolam—GABRA1—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	0.000102	0.0014	CbGpPWpGaD
Ketazolam—GABRB1—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	9.9e-05	0.00136	CbGpPWpGaD
Ketazolam—ALB—SLC-mediated transmembrane transport—SLC6A3—Parkinson's disease	9.51e-05	0.0013	CbGpPWpGaD
Ketazolam—ALB—Platelet activation, signaling and aggregation—SOD1—Parkinson's disease	9.39e-05	0.00129	CbGpPWpGaD
Ketazolam—ALB—Selenium Micronutrient Network—IL1B—Parkinson's disease	9.23e-05	0.00127	CbGpPWpGaD
Ketazolam—ALB—Platelet activation, signaling and aggregation—IGF2—Parkinson's disease	8.92e-05	0.00122	CbGpPWpGaD
Ketazolam—ABCB1—Integrated Pancreatic Cancer Pathway—ABL1—Parkinson's disease	8.82e-05	0.00121	CbGpPWpGaD
Ketazolam—ABCB1—Allograft Rejection—IL1B—Parkinson's disease	8.81e-05	0.00121	CbGpPWpGaD
Ketazolam—ABCB1—Allograft Rejection—CASP3—Parkinson's disease	8.79e-05	0.00121	CbGpPWpGaD
Ketazolam—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—Parkinson's disease	8.68e-05	0.00119	CbGpPWpGaD
Ketazolam—GABRA1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	8.44e-05	0.00116	CbGpPWpGaD
Ketazolam—ALB—Folate Metabolism—TNF—Parkinson's disease	8.43e-05	0.00116	CbGpPWpGaD
Ketazolam—ALB—Platelet activation, signaling and aggregation—HGF—Parkinson's disease	8.42e-05	0.00116	CbGpPWpGaD
Ketazolam—ALB—Vitamin B12 Metabolism—IL6—Parkinson's disease	8.36e-05	0.00115	CbGpPWpGaD
Ketazolam—GABRA1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	8.1e-05	0.00111	CbGpPWpGaD
Ketazolam—CYP3A4—Biological oxidations—CYP2D6—Parkinson's disease	8.01e-05	0.0011	CbGpPWpGaD
Ketazolam—CYP3A4—Metapathway biotransformation—CYP2D6—Parkinson's disease	7.9e-05	0.00108	CbGpPWpGaD
Ketazolam—ALB—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	7.75e-05	0.00106	CbGpPWpGaD
Ketazolam—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—Parkinson's disease	7.71e-05	0.00106	CbGpPWpGaD
Ketazolam—GABRA1—SIDS Susceptibility Pathways—TNF—Parkinson's disease	7.4e-05	0.00101	CbGpPWpGaD
Ketazolam—ALB—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	7.37e-05	0.00101	CbGpPWpGaD
Ketazolam—CYP3A4—Biological oxidations—CYP2E1—Parkinson's disease	7.33e-05	0.00101	CbGpPWpGaD
Ketazolam—ALB—Metabolism—ND3—Parkinson's disease	7.3e-05	0.001	CbGpPWpGaD
Ketazolam—ALB—Metabolism—MCCC1—Parkinson's disease	7.3e-05	0.001	CbGpPWpGaD
Ketazolam—CYP3A4—Metapathway biotransformation—CYP2E1—Parkinson's disease	7.23e-05	0.000992	CbGpPWpGaD
Ketazolam—GABRA1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	7.04e-05	0.000966	CbGpPWpGaD
Ketazolam—ALB—Metabolism—OMD—Parkinson's disease	6.86e-05	0.000941	CbGpPWpGaD
Ketazolam—ALB—Metabolism—TALDO1—Parkinson's disease	6.86e-05	0.000941	CbGpPWpGaD
Ketazolam—ALB—Folate Metabolism—IL6—Parkinson's disease	6.8e-05	0.000933	CbGpPWpGaD
Ketazolam—ALB—Transmembrane transport of small molecules—CP—Parkinson's disease	6.78e-05	0.00093	CbGpPWpGaD
Ketazolam—GABRA1—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	6.76e-05	0.000928	CbGpPWpGaD
Ketazolam—ALB—Selenium Micronutrient Network—TNF—Parkinson's disease	6.69e-05	0.000918	CbGpPWpGaD
Ketazolam—ALB—Hemostasis—FGB—Parkinson's disease	6.52e-05	0.000894	CbGpPWpGaD
Ketazolam—ALB—Metabolism—NDUFB11—Parkinson's disease	6.5e-05	0.000892	CbGpPWpGaD
Ketazolam—ABCB1—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	6.46e-05	0.000886	CbGpPWpGaD
Ketazolam—ABCB1—Allograft Rejection—TNF—Parkinson's disease	6.39e-05	0.000877	CbGpPWpGaD
Ketazolam—ABCB1—Metabolism—MCCC1—Parkinson's disease	6.39e-05	0.000877	CbGpPWpGaD
Ketazolam—ABCB1—Metabolism—ND3—Parkinson's disease	6.39e-05	0.000877	CbGpPWpGaD
Ketazolam—ALB—Metabolism—GCH1—Parkinson's disease	6.2e-05	0.000851	CbGpPWpGaD
Ketazolam—CYP3A4—Biological oxidations—COMT—Parkinson's disease	6.07e-05	0.000833	CbGpPWpGaD
Ketazolam—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	6.04e-05	0.000829	CbGpPWpGaD
Ketazolam—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	6.03e-05	0.000827	CbGpPWpGaD
Ketazolam—ABCB1—Metabolism—TALDO1—Parkinson's disease	6.01e-05	0.000825	CbGpPWpGaD
Ketazolam—ABCB1—Metabolism—OMD—Parkinson's disease	6.01e-05	0.000825	CbGpPWpGaD
Ketazolam—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	5.99e-05	0.000822	CbGpPWpGaD
Ketazolam—GABRA1—SIDS Susceptibility Pathways—IL6—Parkinson's disease	5.97e-05	0.000819	CbGpPWpGaD
Ketazolam—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	5.96e-05	0.000818	CbGpPWpGaD
Ketazolam—ABCB1—Transmembrane transport of small molecules—CP—Parkinson's disease	5.94e-05	0.000815	CbGpPWpGaD
Ketazolam—ABCB1—Metabolism—NDUFB11—Parkinson's disease	5.7e-05	0.000782	CbGpPWpGaD
Ketazolam—ALB—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	5.6e-05	0.000768	CbGpPWpGaD
Ketazolam—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	5.55e-05	0.000762	CbGpPWpGaD
Ketazolam—ALB—Metabolism—GBA—Parkinson's disease	5.53e-05	0.000759	CbGpPWpGaD
Ketazolam—ALB—Metabolism—DBH—Parkinson's disease	5.53e-05	0.000759	CbGpPWpGaD
Ketazolam—ALB—Metabolism—FBP1—Parkinson's disease	5.53e-05	0.000759	CbGpPWpGaD
Ketazolam—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	5.48e-05	0.000752	CbGpPWpGaD
Ketazolam—ABCB1—Metabolism—GCH1—Parkinson's disease	5.44e-05	0.000746	CbGpPWpGaD
Ketazolam—ALB—Selenium Micronutrient Network—IL6—Parkinson's disease	5.4e-05	0.000741	CbGpPWpGaD
Ketazolam—ABCB1—Metabolism—DBH—Parkinson's disease	4.84e-05	0.000665	CbGpPWpGaD
Ketazolam—ABCB1—Metabolism—FBP1—Parkinson's disease	4.84e-05	0.000665	CbGpPWpGaD
Ketazolam—ABCB1—Metabolism—GBA—Parkinson's disease	4.84e-05	0.000665	CbGpPWpGaD
Ketazolam—ALB—Hemostasis—SOD1—Parkinson's disease	4.84e-05	0.000664	CbGpPWpGaD
Ketazolam—ALB—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	4.83e-05	0.000663	CbGpPWpGaD
Ketazolam—ALB—Transmembrane transport of small molecules—CYCS—Parkinson's disease	4.64e-05	0.000636	CbGpPWpGaD
Ketazolam—ALB—Hemostasis—ABL1—Parkinson's disease	4.62e-05	0.000633	CbGpPWpGaD
Ketazolam—ALB—Hemostasis—IGF2—Parkinson's disease	4.6e-05	0.000631	CbGpPWpGaD
Ketazolam—ALB—Hemostasis—HGF—Parkinson's disease	4.34e-05	0.000595	CbGpPWpGaD
Ketazolam—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—Parkinson's disease	4.34e-05	0.000595	CbGpPWpGaD
Ketazolam—ABCB1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	4.23e-05	0.000581	CbGpPWpGaD
Ketazolam—ABCB1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	4.06e-05	0.000558	CbGpPWpGaD
Ketazolam—ALB—Metabolism—DDC—Parkinson's disease	4.06e-05	0.000557	CbGpPWpGaD
Ketazolam—ALB—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	4.03e-05	0.000553	CbGpPWpGaD
Ketazolam—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	3.99e-05	0.000547	CbGpPWpGaD
Ketazolam—CYP3A4—Metabolism—MCCC1—Parkinson's disease	3.94e-05	0.00054	CbGpPWpGaD
Ketazolam—CYP3A4—Metabolism—ND3—Parkinson's disease	3.94e-05	0.00054	CbGpPWpGaD
Ketazolam—ALB—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	3.87e-05	0.000531	CbGpPWpGaD
Ketazolam—ALB—Metabolism—GSTA4—Parkinson's disease	3.83e-05	0.000526	CbGpPWpGaD
Ketazolam—ALB—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	3.78e-05	0.000519	CbGpPWpGaD
Ketazolam—CYP3A4—Metabolism—TALDO1—Parkinson's disease	3.7e-05	0.000508	CbGpPWpGaD
Ketazolam—CYP3A4—Metabolism—OMD—Parkinson's disease	3.7e-05	0.000508	CbGpPWpGaD
Ketazolam—ABCB1—Metabolism—DDC—Parkinson's disease	3.56e-05	0.000488	CbGpPWpGaD
Ketazolam—ABCB1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	3.53e-05	0.000485	CbGpPWpGaD
Ketazolam—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	3.51e-05	0.000482	CbGpPWpGaD
Ketazolam—ALB—Metabolism—PLA2G6—Parkinson's disease	3.45e-05	0.000473	CbGpPWpGaD
Ketazolam—ALB—Metabolism—MAOB—Parkinson's disease	3.42e-05	0.000469	CbGpPWpGaD
Ketazolam—ABCB1—Metabolism—GSTA4—Parkinson's disease	3.36e-05	0.000461	CbGpPWpGaD
Ketazolam—CYP3A4—Metabolism—GCH1—Parkinson's disease	3.35e-05	0.000459	CbGpPWpGaD
Ketazolam—ALB—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	3.25e-05	0.000446	CbGpPWpGaD
Ketazolam—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	3.16e-05	0.000433	CbGpPWpGaD
Ketazolam—ABCB1—Metabolism—PLA2G6—Parkinson's disease	3.02e-05	0.000415	CbGpPWpGaD
Ketazolam—ABCB1—Metabolism—MAOB—Parkinson's disease	2.99e-05	0.000411	CbGpPWpGaD
Ketazolam—CYP3A4—Metabolism—GBA—Parkinson's disease	2.98e-05	0.000409	CbGpPWpGaD
Ketazolam—CYP3A4—Metabolism—FBP1—Parkinson's disease	2.98e-05	0.000409	CbGpPWpGaD
Ketazolam—CYP3A4—Metabolism—DBH—Parkinson's disease	2.98e-05	0.000409	CbGpPWpGaD
Ketazolam—ALB—Metabolism—CYP2D6—Parkinson's disease	2.54e-05	0.000348	CbGpPWpGaD
Ketazolam—ALB—Metabolism—CTGF—Parkinson's disease	2.49e-05	0.000342	CbGpPWpGaD
Ketazolam—ALB—Metabolism—CYP2E1—Parkinson's disease	2.32e-05	0.000319	CbGpPWpGaD
Ketazolam—ALB—Metabolism—NQO1—Parkinson's disease	2.3e-05	0.000315	CbGpPWpGaD
Ketazolam—ALB—Metabolism—TH—Parkinson's disease	2.26e-05	0.00031	CbGpPWpGaD
Ketazolam—ABCB1—Metabolism—CYP2D6—Parkinson's disease	2.22e-05	0.000305	CbGpPWpGaD
Ketazolam—CYP3A4—Metabolism—DDC—Parkinson's disease	2.19e-05	0.000301	CbGpPWpGaD
Ketazolam—ABCB1—Metabolism—CTGF—Parkinson's disease	2.18e-05	0.0003	CbGpPWpGaD
Ketazolam—ALB—Metabolism—CYCS—Parkinson's disease	2.17e-05	0.000298	CbGpPWpGaD
Ketazolam—CYP3A4—Metabolism—GSTA4—Parkinson's disease	2.07e-05	0.000284	CbGpPWpGaD
Ketazolam—ABCB1—Metabolism—CYP2E1—Parkinson's disease	2.03e-05	0.000279	CbGpPWpGaD
Ketazolam—ABCB1—Metabolism—NQO1—Parkinson's disease	2.01e-05	0.000276	CbGpPWpGaD
Ketazolam—ABCB1—Metabolism—TH—Parkinson's disease	1.98e-05	0.000272	CbGpPWpGaD
Ketazolam—ALB—Metabolism—COMT—Parkinson's disease	1.92e-05	0.000264	CbGpPWpGaD
Ketazolam—ALB—Metabolism—GSTP1—Parkinson's disease	1.91e-05	0.000263	CbGpPWpGaD
Ketazolam—ALB—Metabolism—MAOA—Parkinson's disease	1.91e-05	0.000262	CbGpPWpGaD
Ketazolam—ABCB1—Metabolism—CYCS—Parkinson's disease	1.9e-05	0.000261	CbGpPWpGaD
Ketazolam—ALB—Metabolism—HMOX1—Parkinson's disease	1.89e-05	0.000259	CbGpPWpGaD
Ketazolam—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	1.86e-05	0.000256	CbGpPWpGaD
Ketazolam—CYP3A4—Metabolism—MAOB—Parkinson's disease	1.84e-05	0.000253	CbGpPWpGaD
Ketazolam—ALB—Metabolism—ABCB1—Parkinson's disease	1.81e-05	0.000249	CbGpPWpGaD
Ketazolam—ALB—Metabolism—GSTM1—Parkinson's disease	1.76e-05	0.000241	CbGpPWpGaD
Ketazolam—ABCB1—Metabolism—COMT—Parkinson's disease	1.69e-05	0.000231	CbGpPWpGaD
Ketazolam—ALB—Metabolism—GPX1—Parkinson's disease	1.69e-05	0.000231	CbGpPWpGaD
Ketazolam—ABCB1—Metabolism—GSTP1—Parkinson's disease	1.68e-05	0.00023	CbGpPWpGaD
Ketazolam—ABCB1—Metabolism—MAOA—Parkinson's disease	1.67e-05	0.00023	CbGpPWpGaD
Ketazolam—ABCB1—Metabolism—HMOX1—Parkinson's disease	1.65e-05	0.000227	CbGpPWpGaD
Ketazolam—ALB—Metabolism—MTHFR—Parkinson's disease	1.56e-05	0.000213	CbGpPWpGaD
Ketazolam—ABCB1—Metabolism—GSTM1—Parkinson's disease	1.54e-05	0.000212	CbGpPWpGaD
Ketazolam—ABCB1—Metabolism—GPX1—Parkinson's disease	1.48e-05	0.000203	CbGpPWpGaD
Ketazolam—ALB—Metabolism—APOE—Parkinson's disease	1.45e-05	0.000199	CbGpPWpGaD
Ketazolam—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	1.37e-05	0.000188	CbGpPWpGaD
Ketazolam—ABCB1—Metabolism—MTHFR—Parkinson's disease	1.36e-05	0.000187	CbGpPWpGaD
Ketazolam—CYP3A4—Metabolism—CTGF—Parkinson's disease	1.35e-05	0.000185	CbGpPWpGaD
Ketazolam—ABCB1—Metabolism—APOE—Parkinson's disease	1.27e-05	0.000174	CbGpPWpGaD
Ketazolam—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	1.25e-05	0.000172	CbGpPWpGaD
Ketazolam—CYP3A4—Metabolism—NQO1—Parkinson's disease	1.24e-05	0.00017	CbGpPWpGaD
Ketazolam—ALB—Metabolism—INS—Parkinson's disease	1.24e-05	0.00017	CbGpPWpGaD
Ketazolam—CYP3A4—Metabolism—TH—Parkinson's disease	1.22e-05	0.000168	CbGpPWpGaD
Ketazolam—CYP3A4—Metabolism—CYCS—Parkinson's disease	1.17e-05	0.000161	CbGpPWpGaD
Ketazolam—ABCB1—Metabolism—INS—Parkinson's disease	1.08e-05	0.000149	CbGpPWpGaD
Ketazolam—CYP3A4—Metabolism—COMT—Parkinson's disease	1.04e-05	0.000142	CbGpPWpGaD
Ketazolam—CYP3A4—Metabolism—GSTP1—Parkinson's disease	1.03e-05	0.000142	CbGpPWpGaD
Ketazolam—CYP3A4—Metabolism—MAOA—Parkinson's disease	1.03e-05	0.000141	CbGpPWpGaD
Ketazolam—CYP3A4—Metabolism—HMOX1—Parkinson's disease	1.02e-05	0.00014	CbGpPWpGaD
Ketazolam—CYP3A4—Metabolism—ABCB1—Parkinson's disease	9.78e-06	0.000134	CbGpPWpGaD
Ketazolam—CYP3A4—Metabolism—GSTM1—Parkinson's disease	9.5e-06	0.00013	CbGpPWpGaD
Ketazolam—CYP3A4—Metabolism—GPX1—Parkinson's disease	9.1e-06	0.000125	CbGpPWpGaD
Ketazolam—CYP3A4—Metabolism—MTHFR—Parkinson's disease	8.39e-06	0.000115	CbGpPWpGaD
Ketazolam—CYP3A4—Metabolism—APOE—Parkinson's disease	7.82e-06	0.000107	CbGpPWpGaD
Ketazolam—CYP3A4—Metabolism—INS—Parkinson's disease	6.68e-06	9.16e-05	CbGpPWpGaD
